Antiphospholipid antibody–associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone
- 1 May 1996
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 174 (5) , 1584-1589
- https://doi.org/10.1016/s0002-9378(96)70610-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Interaction of Heparin With Antiphospholipid Antibodies (APA) From the Sera of Women With Recurrent Pregnancy Loss (RPL)American Journal of Reproductive Immunology, 1995
- Bone mineral density during long-term prophylaxis with heparin in pregnancyAmerican Journal of Obstetrics and Gynecology, 1994
- Ultrasonographic findings of pregnancy losses after treatment for recurrent pregnancy loss: intravenous immunoglobulin versus placeboFertility and Sterility, 1994
- Inhibition of heparin/antithrombin III cofactor activity by anticardiolipin antibodies: A mechanism for thrombosisThrombosis Research, 1993
- Monoclonal Antibodies to Heparan Sulfate Inhibit the Formation of Thrombin-Antithrombin III ComplexesClinical Immunology and Immunopathology, 1993
- Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatmentAmerican Journal of Obstetrics and Gynecology, 1992
- ANTIPHOSPHOLIPID ANTIBODIESBritish Journal of Haematology, 1990
- Pregnancy-associated immunological disordersCurrent Opinion in Immunology, 1989
- Antiphospholipid Antibodies and Recurrent Pregnancy LossAmerican Journal of Reproductive Immunology, 1989
- Association of lupus anticoagulant with antibody against phosphatidylserineClinical Immunology and Immunopathology, 1987